Catalyst Pharmaceuticals Inc (CPRX)
US$ 24.11-0.86%
Price Chart
Key Statistics
Market Cap
$ 3.1B
P/E Ratio
16.50
Revenue (TTM)
$ 534.65M
Volume
901.21K
52W High
$ 26.58
52W Low
$ 14.75
Dividend Yield
0.00%
Beta
0.72
Technicals
50-Day MA
23.8492
200-Day MA
22.2119
52 Week High
26.58
52 Week Low
14.75
About CPRX
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
Employees
181
Headquarters
Coral Gables, FL
CEO
Mr. Richard John Daly M.B.A.
Latest News
Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue? - Nasdaq
6 days ago • Google News
Strong Inflows Make Catalyst Stock an Outlier - FXEmpire
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg